Oncopharmpod
ESMO 2022 - NICHE-2 and Codebreak 200
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:41
- Mas informaciones
Informações:
Sinopsis
ESMO 2022 is wrapped and two studies in particular have caught our eyes: NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer CODEBREAK: sotorasib vs. docetaxel
